Our study has confirmed the high expression of pHER3 in the AsPC-1 pancreatic cancer cell line by western blotting, and anti-HER3 monoclonal antibody could significantly down-regulated pHER3 level. The gene discussed is ERBB3; the disease is familial pancreatic carcinoma.